Sofwave与Sculptra联合治疗的随机试验
一项前瞻性试点研究:比较即刻联合治疗与序贯治疗——使用注射用聚左旋乳酸与同步超声平行束技术
Evaluation of treatment on the upper arm with Sculptra and Sofwave on the same day versus Sofwave followed by Sculptra 1 month later.
研究概览
详细说明
This is a prospective, single site, split-body, intra-individual comparison pilot study. Each subject serves as their own control. 13 subjects will be recruited for a goal of treatment 10 subjects. One upper extremity (proximal medial arm) will be randomized to receive immediate combination therapy with both injectable poly-L-lactic acid (PLLA, Sculptra®) and synchronous ultrasound parallel beam technology (Sofwave™) administered over the same day. The contralateral arm will undergo sequential therapy, with PLLA administered at baseline and synchronous ultrasound parallel beam treatment one month later (Treatment Visit #2, Day 30).
The study employs a randomized, split-body design to minimize inter-patient variability, with blinded investigator assessment of efficacy outcomes through assessment of standardized digital photographs and video of snap test (skin turgor test). taken during the Final Visit (Day 120).
研究类型
注册 (估计的)
阶段
- 第四阶段
联系人和位置
学习联系方式
- 姓名:Molly Wanner, MD
- 电话号码:6176433885
- 邮箱:mwanner@partners.org
研究联系人备份
- 姓名:Margaret Chou, MD
- 邮箱:mchou3@mgh.harvard.edu
学习地点
-
-
Massachusetts
-
Boston、Massachusetts、美国、02114
- Massachusetts General Hospital
-
接触:
- Margaret Chou, MD
- 邮箱:mchou3@mgh.harvard.edu
-
接触:
- Molly Wanner, MD
- 电话号码:617-643-3885
- 邮箱:mwanner@partners.org
-
首席研究员:
- Molly Wanner, MD
-
副研究员:
- Margaret Chou, MD
-
副研究员:
- Bridget Myers, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Male and female subjects ≥ 40 years old
- Able to provide informed consent
- Baseline level of upper arm skin flaccidity and volume loss as defined as type III or greater on the Arm Visual Analog Scale (Arm VAS) for aging
Exclusion Criteria:
- Prior treatment to the arms with a biostimulatory agent, energy-based device, or skin-tightening device within the past year.
- History of dermabrasion or deep peels involving the upper arms within the past year.
- History of prior surgery involving the upper arms.
- History of prior fat reduction procedures within the upper arms.
- History of keloids, hypertrophic scarring, or connective tissue disorders.
- Active dermatologic condition involving the treatment site.
- Active systemic or local infection or wounds at treatment site.
- History of lymphatic drainage problems involving the upper arms.
- Excessive subcutaneous fat in the upper arms as judged per the investigator.
- Use of immunosuppressive or anticoagulant/antiplatelet medications.
- Uncontrolled medical conditions interfering with wound healing or impacting bleeding.
- Use of weight loss medications or supplements within the month before the baseline visit.
- BMI ≥ 30 kg/m².
- Non-stable weight (>5% change) during the month prior to enrollment.
- Uncontrolled or current hormonal imbalance, including thyroid, pituitary, or androgen-related disorders.
- History of malignancy during the past 5 years.
- Implanted devices, such as pacemaker or defibrillator.
- Active pregnancy, recent pregnancy within the past 3 months, planning to become pregnant during the study period, and/or breastfeeding.
- History of heavy smoking during the past 10 years.
- History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study procedures.
- Known allergy to any topical anesthetics or PLLA.
- Presence of metal implants or metallic foreign bodies within the treatment area (upper arms).
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Sofwave和Sculptra同一天
|
parallel beam ultrasound on arm Sculptra injection into arm |
|
有源比较器:Sofwave与Sculptra间隔一个月
|
parallel beam ultrasound on arm Sculptra injection into arm |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
GAIS skin laxity
大体时间:From treatment to 3 months after treatment
|
5-graded scale: worse; no change; improved; much improved; or very much improved. |
From treatment to 3 months after treatment
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.